November 2, 2026

Lina Hope

The Hidden Risk: Recent Antibiotic Use Linked to Increased Infection Rates in Breast Reconstruction Surgery the-hidden-risk-recent-antibiotic-use-linked-to-increased-infection-rates-in-breast-reconstruction-surgery

The Hidden Risk: Recent Antibiotic Use Linked to Increased Infection Rates in Breast Reconstruction Surgery

Lina Hope August 22, 2026
For millions of women worldwide, the journey toward breast reconstruction following a mastectomy is a pivotal step...
Read More Read more about The Hidden Risk: Recent Antibiotic Use Linked to Increased Infection Rates in Breast Reconstruction Surgery
Breakthrough in Prostate Cancer: Combination Therapy Offers New Hope for Men with Specific Genetic Mutations breakthrough-in-prostate-cancer-combination-therapy-offers-new-hope-for-men-with-specific-genetic-mutations

Breakthrough in Prostate Cancer: Combination Therapy Offers New Hope for Men with Specific Genetic Mutations

Lina Hope August 22, 2026
London, UK – A landmark international study, spearheaded by researchers at University College London (UCL), has unveiled...
Read More Read more about Breakthrough in Prostate Cancer: Combination Therapy Offers New Hope for Men with Specific Genetic Mutations
Abcuro Secures $66 Million Series D to Advance Ulviprubart for Inclusion Body Myositis, Targeting Mid-2028 for Key Trial Results abcuro-secures-66-million-series-d-to-advance-ulviprubart-for-inclusion-body-myositis-targeting-mid-2028-for-key-trial-results

Abcuro Secures $66 Million Series D to Advance Ulviprubart for Inclusion Body Myositis, Targeting Mid-2028 for Key Trial Results

Lina Hope August 19, 2026
Boston, MA – [Insert Date] – Abcuro, a clinical-stage biopharmaceutical company dedicated to developing transformative therapies for...
Read More Read more about Abcuro Secures $66 Million Series D to Advance Ulviprubart for Inclusion Body Myositis, Targeting Mid-2028 for Key Trial Results

You may have missed

a-trojan-horse-in-the-fight-against-cancer-mount-sinai-scientists-unveil-groundbreaking-immunotherapy

A Trojan Horse in the Fight Against Cancer: Mount Sinai Scientists Unveil Groundbreaking Immunotherapy

Rifan Muazin November 1, 2026
bridging-the-gap-how-taylarr-lopez-is-redefining-public-health-communication-and-health-equity

Bridging the Gap: How Taylarr Lopez is Redefining Public Health Communication and Health Equity

Azzam Bilal Chamdy November 1, 2026
the-convergence-of-silicon-and-serum-how-big-tech-is-rewriting-the-rules-of-drug-discovery

The Convergence of Silicon and Serum: How Big Tech is Rewriting the Rules of Drug Discovery

Raul Delapena Setiawan November 1, 2026
Gene therapy abstract concept vector illustration.

Empowering the Frontline: How GeNotes is Revolutionizing Genomic Literacy in the NHS

Azzam Bilal Chamdy November 1, 2026